News | Cath Lab | April 28, 2021

SCAI Updates Best Practices in the Cardiac Cath Lab Guidelines Document

Society for Cardiovascular Angiography and Interventions consensus guidelines provides updates to recommendations provided in 2012 and 2016

A cardiac cath lab at Henry Ford Hospital in Detroit. Photo by Dave Fornell

A cardiac cath lab complex PCI case at Henry Ford Hospital in Detroit. Photo by Dave Fornell


April 28, 2021 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus statement providing cardiologists, cath lab directors, and hospital leadership guidance for contemporary cath lab standards. The document, “SCAI Expert Consensus Update on Best Practices in the Cardiac Catheterization Laboratory” will be presented today at the SCAI 2021 Virtual Scientific Sessions with simultaneous publication in Catheterization & Cardiovascular Interventions.[1]

The statement has been endorsed by the American College of Cardiology Clinical Policy Approval Committee, American Heart Association, and the Heart Rhythm Society.
“First released in 2012, then updated in 2016[2] and now 2021, the document highlights a patient-centric approach to procedures in the cardiac catheterization laboratory, incorporating all the latest advances and standards,” said Srihari S. Naidu, M.D., FSCAI, chair of the writing committee. “Dividing the logistics into the pre-procedure, intra-procedure, and post-procedure periods, and including staffing, quality metrics, industry relations and governance, the document should hopefully further serve as a contemporary look at the optimal running of these busy areas. We have also included areas where operators overlap, such as interventional cardiologists and electrophysiologists, for a more collegial collaborative spirit towards these complex patients and provided guidance on procedures performed in various settings including outpatient labs."

“This comprehensive statement, prepared by experts across a range of disciplines, builds on prior consensus statements and provides updates focused on current patient-centered and evidence-based approaches to care,” said Daniel Kolansky, M.D., FSCAI, vice-chair of the writing committee and SCAI 2021 program chair. “The document covers topics ranging from pre-procedure assessment to intraprocedural best practices and safe discharge and follow-up needs of the patient. The document highlights regulatory and accreditation requirements for cath labs, a heart team approach to complex care, and discussion of what constitutes an optimal cath lab team. It also addresses collaboration between disciplines such as interventional cardiology and cardiac electrophysiology. This document will serve as a guide for lab directors, hospitals, and health systems in establishing current best practices for catheterization labs.”

The new 2021 recommendations include:

   • Emphasis on practical recommendations to optimize quality and outcomes through best practices, registries, risk calculators, and vascular access (radial first, vascular ultrasound)

   • Updated discussion of ambulatory surgery centers and settings without on-site surgery

   • Expanded section on cardiac cath lab (CCL) governance, including dyad leadership, respective roles, “culture-setting,” industry relationships, and patient experience optimization

   • Emphasis on the heart team for various patient subsets, and new recommendations for coordination and collaboration with electrophysiology (EP)

   • Updated pre-procedure checklist and pre-PCI (percutaneous coronary intervention) time out

   • Updated discussion of staff qualifications, certification, and optimal CCL team

   • Updated timing and discussion of patient history and physical (H&P), informed consent, and required blood work

   • Updated infection control guidance, including use of PPE and hand anti-septic solutions

   • Emphasis on same-day discharge for select patients, with discussion of long-term guideline-directed medical therapy (GDMT)  and lifestyle modification, and bedside delivery of medications to improve adherence

The Society for Cardiovascular Angiography and Interventions is a professional organization representing more than 4,000 invasive and interventional cardiology professionals in approximately 75 nations. SCAI's mission is to promote excellence in invasive/interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care.

For more information: www.scai.org

Find more news from the SCAI 2021 virtual meeting

 

References:

1. Srihari S. Naidu, et al. SCAI Expert Consensus Update on Best Practices in the Cardiac Catheterization Laboratory. Catheterization & Cardiovascular Interventions. April 28, 2021. 

2. Srihari S. Naidu, Herbert D. Aronow,  Lyndon C. Box, et al. SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory.02 May 2016 https://doi.org/10.1002/ccd.26551. 

 


Related Content

News | Cardiovascular Business

July 18, 2024 — Circle Cardiovascular Imaging, a developer of artificial intelligence (AI)-driven cardiovascular imaging ...

Home July 18, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
News | Cardiovascular Business

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
News | Cardiovascular Business

July 9, 2024 — Disparities in cardiovascular disease outcomes between urban and rural areas continue to widen, yet ...

Home July 09, 2024
Home
Feature | Cardiovascular Business

The DAIC team wishes you a safe and happy 4th of July!

Home July 04, 2024
Home
News | Cardiovascular Business

July 3, 2024 — Over the past decade, 342 cardiology clinics have been acquired by private equity firms, with over 94% of ...

Home July 03, 2024
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

From FDA approvals to new clinical trials, here is a look at DAIC's top-read content during the month of June: 1 ...

Home July 02, 2024
Home
News | Cardiovascular Business

July 1, 2024 — CVRx, Inc., a commercial-stage medical device company, announced three additions to its senior leadership ...

Home July 01, 2024
Home
News | Cardiovascular Business

June 28, 2024 — After a year of dedicated service and outstanding leadership, Jodie L. Hurwitz, MD, FHRS, has now ended ...

Home June 28, 2024
Home
Subscribe Now